Mary Willis

1.2k total citations
17 papers, 361 citations indexed

About

Mary Willis is a scholar working on Genetics, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Mary Willis has authored 17 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 8 papers in Molecular Biology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Mary Willis's work include Prenatal Screening and Diagnostics (4 papers), Genomic variations and chromosomal abnormalities (4 papers) and Genomics and Rare Diseases (3 papers). Mary Willis is often cited by papers focused on Prenatal Screening and Diagnostics (4 papers), Genomic variations and chromosomal abnormalities (4 papers) and Genomics and Rare Diseases (3 papers). Mary Willis collaborates with scholars based in United States, Canada and Australia. Mary Willis's co-authors include Marilyn C. Jones, Lynne M. Bird, Paul J. Isackson, V. Reid Sutton, Éric Vilain, M. Carrie Miceli, Wayne W. Grody, Donald W. Hadley, Stanley F. Nelson and Joshua L. Deignan and has published in prestigious journals such as The American Journal of Human Genetics, Schizophrenia Bulletin and Journal of Medical Genetics.

In The Last Decade

Mary Willis

16 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Willis United States 10 200 197 72 55 33 17 361
Mathilde Nizon France 13 239 1.2× 153 0.8× 70 1.0× 41 0.7× 26 0.8× 26 387
Sonia Nizard France 10 131 0.7× 227 1.2× 27 0.4× 87 1.6× 62 1.9× 12 357
Mahmoud Taleb Al‐Ali United Arab Emirates 10 174 0.9× 150 0.8× 22 0.3× 44 0.8× 38 1.2× 34 312
Ramin Badii Qatar 12 161 0.8× 123 0.6× 27 0.4× 17 0.3× 14 0.4× 21 394
Michèle Mathieu‐Dramard France 9 200 1.0× 170 0.9× 27 0.4× 44 0.8× 8 0.2× 15 363
Sandesh C. Sreenath Nagamani United States 6 194 1.0× 218 1.1× 33 0.5× 70 1.3× 7 0.2× 8 349
Katalin Szakszon Hungary 10 178 0.9× 103 0.5× 27 0.4× 16 0.3× 30 0.9× 29 276
Kelly E. Jackson United States 8 204 1.0× 211 1.1× 13 0.2× 50 0.9× 26 0.8× 15 375
Emily C. Lisi United States 13 142 0.7× 182 0.9× 35 0.5× 65 1.2× 26 0.8× 22 411
Laila K. Effat Egypt 11 139 0.7× 61 0.3× 47 0.7× 20 0.4× 30 0.9× 29 249

Countries citing papers authored by Mary Willis

Since Specialization
Citations

This map shows the geographic impact of Mary Willis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Willis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Willis more than expected).

Fields of papers citing papers by Mary Willis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Willis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Willis. The network helps show where Mary Willis may publish in the future.

Co-authorship network of co-authors of Mary Willis

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Willis. A scholar is included among the top collaborators of Mary Willis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Willis. Mary Willis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Smith, Laurie D., Mary Willis, Annette Feigenbaum, et al.. (2023). Genome-to-Treatment and Begin Newborn Genomic Screening: A Review of System Guides for the Acute Management and Newborn Screening Follow-up of Genetic Disorders in Infants and Children. Medical Research Archives. 11(10). 1 indexed citations
3.
Willis, Mary, et al.. (2023). A familial case of diffuse cutaneous mastocytosis. The Journal of Allergy and Clinical Immunology In Practice. 11(12). 3802–3803. 4 indexed citations
4.
Fortuna, Ana María, Joana Damásio, Mary Willis, et al.. (2022). Expanding the pre- and postnatal phenotype of WASHC5 and CCDC22 -related Ritscher-Schinzel syndromes. European Journal of Medical Genetics. 65(11). 104624–104624. 4 indexed citations
5.
Willis, Mary, et al.. (2020). Genetic testing costs and compliance with clinical best practices. Journal of Genetic Counseling. 29(6). 1186–1191. 14 indexed citations
6.
Arboleda, Valerie A., Hane Lee, Naghmeh Dorrani, et al.. (2015). De Novo Nonsense Mutations in KAT6A, a Lysine Acetyl-Transferase Gene, Cause a Syndrome Including Microcephaly and Global Developmental Delay. The American Journal of Human Genetics. 96(3). 498–506. 92 indexed citations
7.
Miller, Kyle, Mary Willis, & Scott K. McClatchey. (2015). A case of familial exudative vitreoretinopathy identified after genetic testing. Journal of American Association for Pediatric Ophthalmology and Strabismus. 19(2). 178–180. 1 indexed citations
8.
Bear, Kelly, Benjamin D. Solomon, Sonir Roberto Rauber Antonini, et al.. (2014). Pathogenic mutations in GLI2 cause a specific phenotype that is distinct from holoprosencephaly. Journal of Medical Genetics. 51(6). 413–418. 42 indexed citations
9.
Sheikh, Taimoor I., Kirti Mittal, Mary Willis, & John B. Vincent. (2013). A synonymous change, p.Gly16Gly in MECP2 Exon 1, causes a cryptic splice event in a Rett syndrome patient. Orphanet Journal of Rare Diseases. 8(1). 108–108. 20 indexed citations
10.
Solomon, Benjamin D., Daniel Pineda‐Alvarez, Andrea Gropman, et al.. (2012). High Intellectual Function in Individuals with Mutation-Positive Microform Holoprosencephaly. Molecular Syndromology. 3(3). 140–142. 15 indexed citations
11.
Millson, Alison, Danielle LaGrave, Mary Willis, et al.. (2011). Chromosomal loss of 3q26.3‐3q26.32, involving a partial neuroligin 1 deletion, identified by genomic microarray in a child with microcephaly, seizure disorder, and severe intellectual disability. American Journal of Medical Genetics Part A. 158A(1). 159–165. 20 indexed citations
12.
Dhar, Shweta U., Fernando Scaglia, Laurie D. Smith, et al.. (2008). Expanded clinical and molecular spectrum of guanidinoacetate methyltransferase (GAMT) deficiency. Molecular Genetics and Metabolism. 96(1). 38–43. 45 indexed citations
13.
Willis, Mary, et al.. (2008). Expanding the phenotype of mosaic trisomy 20. American Journal of Medical Genetics Part A. 146A(3). 330–336. 24 indexed citations
14.
Isackson, Paul J., Michael J. Bennett, Uta Lichter‐Konecki, et al.. (2008). CPT2 gene mutations resulting in lethal neonatal or severe infantile carnitine palmitoyltransferase II deficiency. Molecular Genetics and Metabolism. 94(4). 422–427. 41 indexed citations
15.
Willis, Mary, et al.. (2006). Natural history of prenatally diagnosed 46,X,isodicentric Y. Prenatal Diagnosis. 26(2). 134–137. 32 indexed citations
16.
Willis, Mary, et al.. (2006). Expanding the Phenotype of Mosaic Trisomy 20. Journal of Investigative Medicine. 54(1_suppl). 100–100.
17.
Willis, Mary. (1982). The Impact of Schizophrenia on Families: One Mother's Point of View. Schizophrenia Bulletin. 8(4). 617–619. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026